Published • loading... • Updated
Onshoring Is Here. The Hiring Wave Is Still a Decade Out
Guest Commentary Since 2025, pharmaceutical companies have committed more than $370 billion to build manufacturing in the United States—a response to the threat of steep tariffs on imported drugs and to hard lessons about supply chains. If you have been watching for a hiring surge to match the headlines, you have not seen one. That is not a sign the boom stalled. It is a sign of where we are in the cycle. The cranes are up, but the scientists, …
1 Articles
1 Articles
Onshoring Is Here. The Hiring Wave Is Still a Decade Out
Guest Commentary Since 2025, pharmaceutical companies have committed more than $370 billion to build manufacturing in the United States—a response to the threat of steep tariffs on imported drugs and to hard lessons about supply chains. If you have been watching for a hiring surge to match the headlines, you have not seen one. That is not a sign the boom stalled. It is a sign of where we are in the cycle. The cranes are up, but the scientists, …
·New Rochelle, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
